Boehringer’s Hernexeos, Jascayd Just The Start Of A Busy Five-Year Launch Plan

Company Has 80 Projects In The Pipeline

 
• By Mandy Jackson
  
Cancer, pulmonary fibrosis and obesity drugs are among current and potential future Boehringer launches (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from J.P. Morgan

More from Conferences